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Summary Human ovarian carcinoma cells obtained from ascites were tested for susceptibility to lysis by
peripheral blood NK cells, alpha-interferon-activated NK cells, and interleukin 2-activated killer cells.
Cryopreserved tumour cell preparations were used to allow repeated testing of the same target, and the
tumour cells were fractionated using albumin density gradients to determine if fractions containing clonogenic
(stem) cells were killed. Four tumour cell donors were studied and each showed a different pattern of
susceptibility of unfractionated tumour to lysis by different effector cells. Using fractionated tumour cells, we
found that NK and interferon-activated NK cells did not always lyse cells in the clonogenic fractions and that
interferon activation could in some cases shift killing away from the clonogenic fractions and towards the
peak of proliferating (but not self-renewing) colony forming cells. Interleukin 2-activated killer cells (LAK)
however, killed the fractions containing clonogenic cells in all 4 cases. The magnitude of killing seen when
fractions of the original tumour were tested was often striking when compared to lysis of the unfractionated
cells. Apparent heterogeneity between patients and stem cell susceptibility to effector cells may be important
determinants of the efficacy of treatment of patients with biologic response modifiers such as interferon and
interleukin 2.
Non-specific cytotoxic cells of various types have been
proposed to exert significant anti-tumour effects in vivo.
(Hersey et al., 1982; Pross & Rubin, 1982; Vanky et al.,
1984; Jacubovich et al., 1985; Rola-Pleszczynski et al., 1985).
Not uncommonly, such inferences have been based on the
demonstration of killing of tumour target cells in vitro (Pross
& Rubin, 1982). Target cells for these studies have usually
been cultured cell lines. However, 'real' tumours in vivo
consists of heterogeneous collections of cells some of which
are stem cells, some proliferating and differentiating cells,
and many sterile non-dividing end cells (Buick, 1984;
Mackillop & Buick, 1981). Cultured cell lines derived from
the same tumour may differ among each other and differ
from their precursor cells in the original tumour. For
example, it is known that cell culture may produce alter-
ations in chromosome number and may lead to increased
sensitivity to lysis by natural killer (NK) cells present in
human peripheral blood (Shau et al., 1983). In contrast, the
cells of the original tumour when freshly isolated are usually
resistant to lysis (Shau et al., 1983; Vanky et al., 1984).
Alterations in susceptibility to lysis are likely due to either
culture-induced changes in cell phenotype or to selection of a
minor subpopulation whose killing by NK cells is inapparent
when diluted by a large number of NK-resistant cells. We
have recently suggested, for example, that expression of CEA
by tumour cells may correlate with NK susceptibility (Clark
et al., 1984). Not all cells in a CEA-positive tumour express
CEA, and in the case of ovarian carcinoma, only cells at an
early stage of differentiation appear to express the antigen
(Buick et al., 1983). Therefore, it was particularly important
to determine if stem cells might be killed by NK cells.
Recently it has become apparent that freshly isolated NK-
resistant tumour cells may be efficiently lysed by interleukin-
2 activated lymphocytes (LAK) (Grimm et al., 1982). It was
therefore of additional interest to determine if susceptibility
to LAK might include the stem cell population.
Using colony assays, cell surface markers, and density
gradient separations it has been possible to separate and
identify different cellular elements in fresh uncultured ovar-
ian carcinoma ascites (Mackillop & Buick, 1981; Buick et al.,
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1983). The colony-forming and self-renewing colony forming
cells (putative stem cells) have been assigned to specific
subpopulations (Mackillop & Buick, 1981). This system
possessed the additional advantage that no enzymes needed
to be used for disaggregation, tumours could be selected
where host cell contamination was less than 5% and tumour
frozen with aliquots thawed for repeated testing thereby
allowing studies of tumours from individual patients to be
repeated. Thus the effect of NK cells, interferon-activated
NK cells, and LAK from a standard donor could be
repeatedly tested on subpopulations of the same patient. The
data suggest that distinct tumour subpopulations are sensi-
tive to these effector cells but the pattern of subpopulation
killing may be different for each effector cell population.
With some tumours, interferon-activation of NK cells shifted
the pattern of killing towards non-stem cell fractions con-
taining colony-forming cells. LAK most consistently killed
the fractions containing stem cells, but interestingly, lytic
activity could disappear if unfractionated target cells were
used. These findings and the marked heterogeneity between
individual patient's tumours may have treatment impli-
cations that can be tested in vivo.
Materials and methods
Target cells
Procurement of ascites from ovarian carcinoma patients has
been described previously. Twelve of 250 patients provided
at least 108 cells with less than 5% non-tumour cells in
single cell suspension, and these were frozen in aliquots in
10% DMSO (Mackillop & Buick, 1981; Buick et al., 1983;
Buick, 1984). Aliquots were thawed for use and separated
using albumin density gradients as previously described
(Mackillop & Buick, 1981). The reproducibility of our
gradients based on the peak of the cell distribution profile
was +1 density step.
Effector cells for cytotoxic assays
Lymphocytes were routinely isolated from heparinized
venous blood provided by one of the authors, using hypaque
ficoll (density 1.077). The PBL were used fresh as a source of
Br. J. Cancer (I988) 58, 415-418416 D.A. CLARK et al.
endogenous NK cell activity, or after a 0.5-1 h incubation at
37"C with 100units ml-1 recombinant alpha-interferon
(kindly provided by Hoffman-LaRoche). LAKs were
obtained by culturing PBL at 5x 106ml-1 in RPMI 1640
with 10% foetal bovine serum, 100 iuml- 1 penicillin G,
100l g ml-' streptomycin (Grand Island Biol. Co., Grand
Island, NY) together with 10% lectin-free interleukin 2
(Assoc. Biomed. Systems, Buffalo, NY). After 4 days, the
cells were harvested for testing.
SlCr-release assay
Unseparated and albumin gradient-fractionated tumour cells
were incubated 45min with 200pCiml 1 sodium 51chromate
and washed. Target cells (5 x 103) were added to quadrupli-
cate wells of flat bottom 96 well microtrays (Linbro)
together with medium (as described above but minus inter-
leukin 2), or 2% NP-40, or with medium containing effector
test cells at a ratio of effector to target cells ranging from
50:1-25: 1. Due to the limited number of target cells obtain-
able from the density gradient fractions, it was usually only
possible to test two types of effector cells in an experiment.
After 16-20h incubation at 37°C in 7% CO2, an aliquot of
supernatant was removed and % specific 51Cr-release calcu-
lated from,
(CPM with effector cells - CPM spontaneously
P=100°/ xreleased in medium)
(Total releasable CPM NP-40 - CPM
spontaneously released in medium)
Table I Sensitivity of ovarian carcinoma target cells to different
types of cytotoxic effector cell populations
% Specific 51Cr-release with
Tumour used
as targets PBL-NK cells IFN-NK cellsa LAKb
No. I (PR) 4.0+2.6 (3)C 20.6+4.0 (3)c 35.1 +4.4 (1)
No. 2 (SA) 2.8+2.7 (3)c 5.6± 3.4 (3)c 0±0 (3)c
No. 3 (BA) 11.6+3.0 (3)c 13.0+5.8 (3)c 5.9+5.9 (3)c
No. 4 (OW) 5.3±2.0 (3)C 0.9±0.5 (2) 39.8±0.9 (2)c
aMononuclear cells isolated from peripheral blood (PBL) and
activated by incubation with alpha interferon as described in
Materials and methods; bPBL mononuclear cells cultured for 4 days
in vitro with interleukin 2; cParentheses show number of experiments
used to compute mean +s.e.m. Where only I determination was
done, the mean+s.e.m. is given for the 4 replicates in the assay.
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The mean and s.e.m. from 4-6 replicates was determined.
Colony assay
The ability of unfractionated tumour cells to form colonies
was determined as described elsewhere (Mackillop & Buick,
1981; Buick, 1984). Briefly, OW tumour cells which retained
colony forming ability after freezing were thawed and plated
in methylcellulose; the triplicate dishes were incubated for 1-
3 weeks, and colonies of 64 or more cells counted. These
larger colonies have been shown to correlate with the
presence of colony forming cell self-renewal (Buick, 1984). In
some experiments, the tumour cells were incubated overnight
at 37°C with PBL or LAK in 50ml plastic centrifuge tubes
(Falcon) prior to plating. NK and LAK effector cells were
irradiated (2.5Gy 137Cs) to prevent proliferation and pos-
sible colony formation, and an aliquot of the effector cells
was added to the methylcellulose plus untreated tumour cells
to test for an effect on colony formation independent of
contact occurring during the overnight preincubation.
Statistics
The significance of differences was assessed using Student's
t test.
Results
The susceptibility of unseparated ovarian tumour cells to
lysis by different effector cell types is shown in Table I.
None of the tumours proved very sensitive to lysis by NK
activity. Tumour no. 1 (PR) was sensitive (>10% lysis) to
IFN-NK, and LAK killing whereas tumour no. 2 (SA) was
relatively resistant; tumour no. 4 (OW) showed a different
pattern with susceptibility only to LAK killing whereas
tumour no. 3 (BA) was suceptible to lysis by PBL-NK and
interferon-activated NK cells. To determine if all the cell
types in a 'resistant' tumour were so, we separated the
tumour cells by density and tested each fraction with differ-
ent effector populations.
Several patterns of killing were noted and depended on the
particular tumour. Figure 1a illustrates the result from
patient no. 1 (PR). The NK-susceptible cells were found in
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Figure 1 Separation of human ovarian carcinoma cells by
density fractionation. Panel (a) patient no. 1 (PR) and (b) patient
no. 2 (SA). A discontinuous step gradient 1.012 to 1.088 was
used, and (0) shows the cell distribution profile. The susceptibi-
lity of cells in each fraction was assessed by 51Cr release using
fresh PBL as a source of NK cells (A) and interferon-activated
PBL-NK (A), or LAKs (A). An effector: target ratio of 50:1
was used in (a) and 25:1 in (b).
two peaks. The peak on the left correlated with the peak of
proliferating colony -forming cells, as described previously
(Mackillop & Buick, 1981). The second peak of cytotoxicity
was noted to the right, (stem cells have been localized
primarily in fractions 5 & 6 with some in 4 & 7). Interferon
activation boosted killing of both populations and promoted
some killing of cells in fractions 5 & 6. In a single
experiment done to evaluate killing by LAK, peak killing
was associated with tumour cells belonging to fractions 5-7
(data not shown). Figure lb shows the result obtained with a
second patient (SA). Again, two peaks of killing by PBL NK
activity were seen. Interferon activation boosted lysis, but
interestingly, the right hand peak that should be associated
with stem cells was significantly attenuated whereas the left
hand peak associated with the proliferative cell peak was
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cytotoxicity that associated with the right hand peak and
was active in those fractions expected to contain stem cells.
Figure 2 shows a third patient (BA). In Figure 2a one can
again see the two peaks of killing with PBL-NK, and as with
patient SA, interferon activation boosted the left hand peak
and attenuated the right hand peak. LAK activity (Figure
2b) reproducibly showed 3 peaks of activity, with substantial
activity against fractions that were not particularly suscep-
tible to activated NK cells. The same pattern of killing was
reproduced using interferon and IL-2 activated PBL from a
second normal donor.
Figure 3a shows a fourth patient (OW). The individual
fractions of the tumour were quite resistant to killing. Figure
3b shows that some fractions could be killed above 10% by
interferon activated NK cells and 2-3 peaks of activity could
be discerned. In contrast, LAK produced substantial lysis,
including those fractions expected to contain stem cells.
Although LAK appeared to kill fractions expected to
contain stem cells, the lysis of stem-cell enriched fractions
was seldom >50% and since the frequency of stem cells has
been estimated to be less than 1/50, (Mackillop & Buick,
1981) it was quite possible that stem cells were not being
killed by LAK. It was possible to directly test whether or
not stem cells were killed by LAK using the OW cell line
that has retained its ability to form colonies in spite of liquid
nitrogen storage. OW tumour cells (Figure 3) that were
sensitive to LAK but resistant to NK cell killing were
incubated with effector cells at a ratio of 25-100:1 in
plastic tubes overnight at 37°C as described in Materials and
methods and then were plated in methylcellulose. The
presence of irradiated PBL (or LAK) prevented from con-
tacting the targets enhanced colony formation. In contrast,
direct contact with LAK markedly reduced colony formation
to levels below the medium only control (Table II). These
data were compatible with the thesis that colony forming
cells were killed. Indeed, these colonies were smaller in size,
consistent with killing of self-renewing cells.
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Figure 2 Separation of ovarian carcinoma from patient no. 3
(BA). Symbols are as used in Figure 1. An effector:target ratio
of 30:1 was used in (a) and 50:1 in (b).
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Figure 3 Study of patient no. 4 (OW) ovarian tumour by
density fractionation. Symbols are as used in Figure 1. An
effector:target ratio of 50:1 was used.
Table II Effect of NK and LAK on colony formation by
OW cells
Number of colonies+s.e.m.
Initial treatment per cultureb
Nil 23+4.8
Nil+3 x 106 LAKa 62+7.9
I x 106 PBL (25: 1) 73+8.5
2 x 106 PBL (50: 1) 90+9.5
4x 106 PBL (100: 1) 78+8.8
I x 106 LAK (25: 1) 17+4.Id
2 x 106 LAK (50:1) 13+3.6d
4x 106 LAK (100:l)c 5+2.2d
aIncubated separately and added to the target cells at time
of plating in methylcellulose to prevent direct cell contact and
to test for feeder effects; b4 x 104OW cells; CEffector:target
ratio; dSignificant reduction compared to control with LAK
feeder cells. LAK killing of colony forming cells has been
reproduced using another patient's tumour recently obtained
and stored frozen.
Discussion
The data in this paper provide a comparison of the sensi-
tivity of ovarian carcinoma cells to lysis by 3 types of non-
specific effector cells. The patterns shown were reproducible
for a given patient. It is apparent that each tumour gave a
different pattern, consistent with the idea that patients are
different. Using a second donor, we confirmed with target
BA that the pattern of lysis of different fractions of the
tumour was a property of the tumour and not of the donor.
Within a given tumour there was also heterogeneity as
shown by variation in susceptibility to killing among tumour
subpopulations of different density. Since the CEA marker
has been found with these tumours primarily in fractions
4-6, this molecule would not appear to correlate with
susceptibility to lysis by PBL-NK cells as suggested for
colonic and breast neoplasms (Buick, 1984; Clark et al.,
1984).
A second point that may be drawn from the data is that
killing by NK and interferon-activated NK cells often
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'spared' those fractions expected to contain the bulk of the
self-renewing stem cell population. Indeed, interferon activa-
tion could increase net killing, but shift the spectrum of
cytotoxicity away from the stem cell-containing fractions!
LAK proved more cytotoxic to the fractions expected to
contain stem cells and preliminary data using the OW cell
line indicated colony forming cells were killed.
A third point that can be drawn from the data is
illustrated by tumours such as BA and SA that showed little
if any killing of unseparated tumour cells but quite respec-
table killing of particular fractions of separated tumour.
Indeed, the lack of lysis of unseparated tumour would not
have been expected from the curves shown in Figure lb and
Figure 2. There are two possible interpretations of these
data. First, it is possible that density gradient fractionation
separated and concentrated susceptible and resistant target
cells (Roozemond et al., 1986). The probability of a suscep-
tible target being lysed is proportional to the probability of
an encounter with an effector cell, and this in turn is
determined by the concentration of targets and effectors. The
frequency of susceptible targets might be 1/3 in a particular
fraction but only 1/30 in whole tumour. Therefore, signifi-
cant lysis of unseparated tumour cells might be missed.
Second, it is possible that lysis of susceptible targets was
suppressed by other cells present in the unseparated tumour.
Suppression of cytolytic effectors by suppressor cell
activity in tumour has required preincubation with effector
cells prior to testing on target cells (Introna et al., 1982;
Uchida & Micksche, 1982; Haskill et al., 1982). Only
alveolar macrophages have been shown to inhibit killing by
NK cells when added directly to the assay itself (Bordignon
et al., 1982). However, in other systems, cells exist that can
directly inhibit killing by cytolytic effector cells. A subpopu-
lation of cells in the placenta can block target killing by NK,
ADCC, LAK, and CTL (Clark & Chaouat, 1986). Host
macrophages have been implicated as suppressor cells in
preincubation assays, but it should also be noted that
Whiteside et al. (1986) have indicated tumour cells may also
render unresponsive potential effector lymphocytes within a
tumour. In the context of tumours, it may not be the host's
lymphomyeloid cells that are suppressive but rather the
tumour cells themselves (Vose & Moore, 1979). Preliminary
experiments done recently in our laboratory suggest that
unseparated ovarian carcinoma cells can suppress lysis of
susceptible subpopulations by interferon activated NK cells.
The nature of this inhibition and whether it can account for
variation in susceptibility of different fractions of the tumour
is currently being examined.
On the basis of the data in this paper, one may speculate
that it will be important to know the sensitivity pattern of
tumour subpopulations for each patient when biological
response modifiers are being used and to know if there are
inhibitors in the tumour that might inactivate the relevant
effector cells. However, one must stress that the data in this
paper have been obtained using effector cells that are
allogeneic. For most of the studies, a single donor was used
in order to keep one unknown in the system (ie the effector
cells) constant while the second unknown (ie the source of
the tumour cells) was varied. Now that we have evidence for
differences between patient's tumours, the next step will be
to study autochthonous cell activity using the patient's own
effector cells. Unfortunately, such studies could not be done
using our frozen stored tumour cell stock used in the study
described in this paper because no PBL had been stored at
the time the patients were alive.
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